Concepedia

Dorothea Horvath

DH

Statistics

Publications

5

Citations

679

H-Index

5

Active since

2002

Affiliations

University of Wisconsin Carbone Cancer Center(Current)

Wisconsin Institutes for Discovery

University of Wisconsin–Madison

Dorothea Horvath is an author at University of Wisconsin Carbone Cancer Center specializing in medicine, oncology, and pharmacology.

Publications per year

2002–2011

5

Publications

5

Safety and Immunological Efficacy of a DNA Vaccine Encoding Prostatic Acid Phosphatase in Patients With Stage D0 Prostate Cancer

Douglas G. McNeel, Edward J. Dunphy, James G. Davies et al. · Journal of Clinical Oncology · 2009 · 250 citations · Full text

, , +17

A Phase II Multicenter, Randomized, Double-Blind, Safety Trial Assessing the Pharmacokinetics, Pharmacodynamics, and Efficacy of Oral 2-Methoxyestradiol Capsules in Hormone-Refractory Prostate Cancer

Christopher J. Sweeney, Glenn Liu, Constantin T. Yiannoutsos et al. · Clinical Cancer Research · 2005 · 173 citations · Full text

, , +16

Pilot trial of interleukin-2 and zoledronic acid to augment γδ T cells as treatment for patients with refractory renal cell carcinoma

Joshua M. Lang, Mahazarin R. Kaikobad, Marianne Wallace et al. · Cancer Immunology Immunotherapy · 2011 · 132 citations · Full text

, , +11

Phase I trial of 1alpha-hydroxyvitamin d(2) in patients with hormone refractory prostate cancer.

Glenn Liu, Kurt R. Oettel, Gregory H. Ripple et al. · PubMed · 2002 · 65 citations

, , +15

Phase II trial of perillyl alcohol (NSC 641066) administered daily in patients with metastatic androgen independent prostate cancer

Glenn Liu, Kurt R. Oettel, Howard H. Bailey et al. · Investigational New Drugs · 2003 · 59 citations

, , +8

1–5 of 5